A possible association between aldosterone response to vasopressin and circadian change of aldosterone in the patients with aldosterone-producing adenoma

Peptides

Volumn 29, Issue 12, 2008, Pages 2225-2231

  Suzuki, Sawako ^a,b   Uchida, Daigaku ^a,b   Koide, Hisashi ^a,b   Suyama, Keiko ^a,b   Shibata, Takahisa ^a,b   Yoshida, Tomohiko ^a,b   Tanaka, Tomoaki ^a,b   Noguchi, Yoshihiko ^a,b   Saito, Yasushi ^a,b   Tatsuno, Ichiro ^a,b  

^a CHIBA UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Aldosterone; Aldosterone producing adenoma; Circadian change; V1a receptor; Vasopressin

Indexed keywords

ALDOSTERONE; MESSENGER RNA; VASOPRESSIN; VASOPRESSIN V1A RECEPTOR;

ADENOMA; ADRENAL GLAND; ADRENAL TUMOR; ADULT; AGED; ALDOSTERONE BLOOD LEVEL; ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE RELEASE; HORMONE RESPONSE; HUMAN; HUMAN CELL; LOADING TEST; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ADENOMA; ADRENAL GLANDS; AGED; ALDOSTERONE; CIRCADIAN RHYTHM; CUSHING SYNDROME; FEMALE; HUMANS; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; PROSPECTIVE STUDIES; RECEPTORS, VASOPRESSIN; RNA, MESSENGER; VASOPRESSINS;

EID: 55949099880     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2008.09.001     Document Type: Article

References (36)

1. Arnaldi G., Gasc J.M., de Keyzer Y., Raffin-Sanson M.L., Perraudin V., Kuhn J.M., et al. Variable expression of the V1 vasopressin receptor modulates the phenotypic response of steroid-secreting adrenocortical tumors. J Clin Endocrinol Metab 83 (1998) 2029-2035
2. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo Jr. J.L., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289 (2003) 2560-2572
3. Conn J.W. Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome. J Lab Clin Med 45 (1955) 3-17
4. Delarue C., Contesse V., Lenglet S., Sicard F., Perraudin V., Lefebvre H., et al. Role of neurotransmitters and neuropeptides in the regulation of the adrenal cortex. Rev Endocr Metab Disord 2 (2001) 253-267
5. Fardella C.E., Mosso L., Gomez-Sanchez C., Cortes P., Soto J., Gomez L., et al. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab 85 (2000) 1863-1867
6. Giacchetti G., Mulatero P., Mantero F., Veglio F., Boscaro M., and Fallo F. Primary aldosteronism, a major form of low renin hypertension: from screening to diagnosis. Trends Endocrinol Metab 19 (2008) 104-108
7. Gordon R.D., Stowasser M., Tunny T.J., Klemm S.A., and Rutherford J.C. High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 21 (1994) 315-318
8. Gregoire J.R. Adjustment of the osmostat in primary aldosteronism. Mayo Clin Proc 69 (1994) 1108-1110
9. Guillon G., Trueba M., Joubert D., Grazzini E., Chouinard L., Cote M., et al. Vasopressin stimulates steroid secretion in human adrenal glands: comparison with angiotensin-II effect. Endocrinology 136 (1995) 1285-1295
10. Holland O.B., Brown H., Kuhnert L., Fairchild C., Risk M., and Gomez-Sanchez C.E. Further evaluation of saline infusion for the diagnosis of primary aldosteronism. Hypertension 6 (1984) 717-723
11. Kem D.C., Weinberger M.H., Gomez-Sanchez C., Kramer N.J., Lerman R., Furuyama S., et al. Circadian rhythm of plasma aldosterone concentration in patients with primary aldosteronism. J Clin Invest 52 (1973) 2272-2277
12. Kem D.C., Weinberger M.H., Mayes D.M., and Nugent C.A. Saline suppression of plasma aldosterone in hypertension. Arch Intern Med 128 (1971) 380-386
13. Kimura T., Yamamoto T., Ohta M., Ota K., Shoji M., Funyu T., et al. Impaired vasopressin suppression and enhanced atrial natriuretic hormone release following an acute water load in primary aldosteronism. Eur J Endocrinol 137 (1997) 154-161
14. Kumar A., Lall S.B., Ammini A., Peshin S.S., Karmarkar M.G., Talwar K.K., et al. Screening of a population of young hypertensives for primary hyperaldosteronism. J Hum Hypertens 8 (1994) 731-732
15. Lacroix A., Ndiaye N., Tremblay J., and Hamet P. Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome. Endocr Rev 22 (2001) 75-110
16. Lacroix A., Tremblay J., Touyz R.M., Deng L.Y., Lariviere R., Cusson J.R., et al. Abnormal adrenal and vascular responses to vasopressin mediated by a V1-vasopressin receptor in a patient with adrenocorticotropin-independent macronodular adrenal hyperplasia, Cushing's syndrome, and orthostatic hypotension. J Clin Endocrinol Metab 82 (1997) 2414-2422
17. Lim P.O., Dow E., Brennan G., Jung R.T., and MacDonald T.M. High prevalence of primary aldosteronism in the Tayside hypertension clinic population. J Hum Hypertens 14 (2000) 311-315
18. Loh K.C., Koay E.S., Khaw M.C., Emmanuel S.C., and Young Jr. W.F. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab 85 (2000) 2854-2859
19. Lyons D.F., Kem D.C., Brown R.D., Hanson C.S., and Carollo M.L. Single dose captopril as a diagnostic test for primary aldosteronism. J Clin Endocrinol Metab 57 (1983) 892-896
20. Mulatero P., Stowasser M., Loh K.C., Fardella C.E., Gordon R.D., Mosso L., et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 89 (2004) 1045-1050
21. Newell-Price J., Bertagna X., Grossman A.B., and Nieman L.K. Cushing's syndrome. Lancet 367 (2006) 1605-1617
22. Nishikawa T., Saito J., and Omura M. Is primary aldosteronism rare or common among hypertensive patients?. Hypertens Res 30 (2007) 103-104
23. No authors listed. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997;157:2413-46.
24. Omura M., Sasano H., Saito J., Yamaguchi K., Kakuta Y., and Nishikawa T. Clinical characteristics of aldosterone-producing microadenoma, macroadenoma, and idiopathic hyperaldosteronism in 93 patients with primary aldosteronism. Hypertens Res 29 (2006) 883-889
25. Perraudin V., Delarue C., De Keyzer Y., Bertagna X., Kuhn J.M., Contesse V., et al. Vasopressin-responsive adrenocortical tumor in a mild Cushing's syndrome: in vivo and in vitro studies. J Clin Endocrinol Metab 80 (1995) 2661-2667
26. Perraudin V., Delarue C., Lefebvre H., Contesse V., Kuhn J.M., and Vaudry H. Vasopressin stimulates cortisol secretion from human adrenocortical tissue through activation of V1 receptors. J Clin Endocrinol Metab 76 (1993) 1522-1528
27. Perraudin V., Delarue C., Lefebvre H., Do Rego J.L., Vaudry H., and Kuhn J.M. Evidence for a role of vasopressin in the control of aldosterone secretion in primary aldosteronism: in vitro and in vivo studies. J Clin Endocrinol Metab 91 (2006) 1566-1572
28. Reznik Y., Lefebvre H., Rohmer V., Charbonnel B., Tabarin A., Rodien P., et al. Aberrant adrenal sensitivity to multiple ligands in unilateral incidentaloma with subclinical autonomous cortisol hypersecretion: a prospective clinical study. Clin Endocrinol (Oxf) 61 (2004) 311-319
29. Rossi E., Regolisti G., Negro A., Sani C., Davoli S., and Perazzoli F. High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives. Am J Hypertens 15 (2002) 896-902
30. Rossi G.P., Belfiore A., Bernini G., Desideri G., Fabris B., Ferri C., et al. Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma. Hypertension 50 (2007) 424-431
31. Saner-Amigh K., Mayhew B.A., Mantero F., Schiavi F., White P.C., Rao C.V., et al. Elevated expression of luteinizing hormone receptor in aldosterone-producing adenomas. J Clin Endocrinol Metab 91 (2006) 1136-1142
32. Suzuki S., Uchida D., Koide H., Tanaka T., Noguchi Y., Saito Y., et al. Hyper-responsiveness of adrenal gland to vasopressin resulting in enhanced plasma cortisol in patients with adrenal nodule(s). Peptides 29 (2008) 1767-1772
33. Tatsuno I., Uchida D., Tanaka T., Koide H., Shigeta A., Ichikawa T., et al. Vasopressin responsiveness of subclinical Cushing's syndrome due to ACTH-independent macronodular adrenocortical hyperplasia. Clin Endocrinol (Oxf) 60 (2004) 192-200
34. Thibonnier M., Plouin P.F., Menard J., and Corvol P. [Primary hyperaldosteronism: diagnostic value of the administration of a single dose of captopril]. Ann Med Interne (Paris) 134 (1983) 251-255
35. Vasan R.S., Evans J.C., Larson M.G., Wilson P.W., Meigs J.B., Rifai N., et al. Serum aldosterone and the incidence of hypertension in nonhypertensive persons. N Engl J Med 351 (2004) 33-41
36. Weiss L.M. Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol 8 (1984) 163-169